Mahindra Lifespace Developers Limited has informed the Exchange about press release dated 12-Apr-2022 titled Mahindra Lifespaces launches India???s First Net Zero Energy Homes in Bengaluru
Promoter/Promoter Group of Power Finance Corporation Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
MEDICAMEQ : Significant movement in price has been observed in Medicamen Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Medicamen Biotech Limited has submitted their response.
Promoters of Kilitch Drugs (India) Limited has informed the Exchange about Disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers)Regulations, 2011.
Tata Steel Limited has informed the Exchange about Acquisition of entire stake held by Steel Authority of India Limited in S&T MiningCompany Limited
Promoter/Promoter Group of Setco Automotive Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Fairchem Organics Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 12-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.
Jaiprakash Associates Limited has informed the Exchange about Notice of Postal Ballot
Cyient Limited has informed the Exchange about press release dated 12-Apr-2022 titled Cyient Named as a Major Contender in the Everest Group PEAK Matrix?? for Digital Product Engineering Service Provider 2022

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.